Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission-Reference-Cited by-同舟云学术

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission

Published:2020-04 Issue:2 Volume:50 Page:276-284
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Aletaha Daniel,Wang Xin,Zhong Sheng,Florentinus Stefan,Monastiriakos Kelly,Smolen Josef S.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference38 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

2. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

3. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis;Aletaha;Clin Exp Rheumatol,2005

4. American College of Rheumatology/European League Against Rheumatism preliminary definition of remission in rheumatoid arthritis for clinical trials;Felson;Arthritis Rheum,2011

5. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Cl

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry;Rheumatology and Therapy;2024-04-18

2. Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis;Clinical Rheumatology;2024-02-14

3. Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg;Arthritis Research & Therapy;2024-02-08

4. Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort;Arthritis Research & Therapy;2024-01-09

5. The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients;Scientific Reports;2023-08-25